In particular, the significant decrease in IL-6 levels and improvements in IBS symptoms corroborate previous findings pointing to IL-6 as the most potentially interesting cytokine biomarker of IBS(6,13). The gene discussed is IL6; the disease is irritable bowel syndrome.